Bio-Techne Corp
NASDAQ:TECH

Watchlist Manager
Bio-Techne Corp Logo
Bio-Techne Corp
NASDAQ:TECH
Watchlist
Price: 73.03 USD 0.4% Market Closed
Market Cap: 11.6B USD
Have any thoughts about
Bio-Techne Corp?
Write Note

Intrinsic Value

The intrinsic value of one TECH stock under the Base Case scenario is 57.79 USD. Compared to the current market price of 73.03 USD, Bio-Techne Corp is Overvalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TECH Intrinsic Value
57.79 USD
Overvaluation 21%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Bio-Techne Corp

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for TECH cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about TECH?
Bearish
Neutral
Bullish

Fundamental Analysis

73.03 USD
+0.4%
+0.4%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Bio-Techne Corp
US
Life Sciences Tools & Services
Market Cap
11.6B USD
IPO
Feb 9, 1989
Employees
2 600
United States of America
Market Cap
11.6B USD
Industry
Life Sciences Tools & Services
IPO
Feb 9, 1989
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Bio-Techne Corp

Provide an overview of the primary business activities
of Bio-Techne Corp.

What unique competitive advantages
does Bio-Techne Corp hold over its rivals?

What risks and challenges
does Bio-Techne Corp face in the near future?

Has there been any significant insider trading activity
in Bio-Techne Corp recently?

Summarize the latest earnings call
of Bio-Techne Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bio-Techne Corp.

Provide P/S
for Bio-Techne Corp.

Provide P/E
for Bio-Techne Corp.

Provide P/OCF
for Bio-Techne Corp.

Provide P/FCFE
for Bio-Techne Corp.

Provide P/B
for Bio-Techne Corp.

Provide EV/S
for Bio-Techne Corp.

Provide EV/GP
for Bio-Techne Corp.

Provide EV/EBITDA
for Bio-Techne Corp.

Provide EV/EBIT
for Bio-Techne Corp.

Provide EV/OCF
for Bio-Techne Corp.

Provide EV/FCFF
for Bio-Techne Corp.

Provide EV/IC
for Bio-Techne Corp.

Show me price targets
for Bio-Techne Corp made by professional analysts.

What are the Revenue projections
for Bio-Techne Corp?

How accurate were the past Revenue estimates
for Bio-Techne Corp?

What are the Net Income projections
for Bio-Techne Corp?

How accurate were the past Net Income estimates
for Bio-Techne Corp?

What are the EPS projections
for Bio-Techne Corp?

How accurate were the past EPS estimates
for Bio-Techne Corp?

What are the EBIT projections
for Bio-Techne Corp?

How accurate were the past EBIT estimates
for Bio-Techne Corp?

Compare the revenue forecasts
for Bio-Techne Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bio-Techne Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bio-Techne Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bio-Techne Corp compared to its peers.

Compare the P/E ratios
of Bio-Techne Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Bio-Techne Corp with its peers.

Analyze the financial leverage
of Bio-Techne Corp compared to its main competitors.

Show all profitability ratios
for Bio-Techne Corp.

Provide ROE
for Bio-Techne Corp.

Provide ROA
for Bio-Techne Corp.

Provide ROIC
for Bio-Techne Corp.

Provide ROCE
for Bio-Techne Corp.

Provide Gross Margin
for Bio-Techne Corp.

Provide Operating Margin
for Bio-Techne Corp.

Provide Net Margin
for Bio-Techne Corp.

Provide FCF Margin
for Bio-Techne Corp.

Show all solvency ratios
for Bio-Techne Corp.

Provide D/E Ratio
for Bio-Techne Corp.

Provide D/A Ratio
for Bio-Techne Corp.

Provide Interest Coverage Ratio
for Bio-Techne Corp.

Provide Altman Z-Score Ratio
for Bio-Techne Corp.

Provide Quick Ratio
for Bio-Techne Corp.

Provide Current Ratio
for Bio-Techne Corp.

Provide Cash Ratio
for Bio-Techne Corp.

What is the historical Revenue growth
over the last 5 years for Bio-Techne Corp?

What is the historical Net Income growth
over the last 5 years for Bio-Techne Corp?

What is the current Free Cash Flow
of Bio-Techne Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bio-Techne Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bio-Techne Corp

Current Assets 648.6m
Cash & Short-Term Investments 187.5m
Receivables 223.7m
Other Current Assets 237.3m
Non-Current Assets 2.1B
Long-Term Investments 256.3m
PP&E 343.2m
Intangibles 1.5B
Other Non-Current Assets 19.4m
Current Liabilities 142.1m
Accounts Payable 31.6m
Accrued Liabilities 76.6m
Other Current Liabilities 34m
Non-Current Liabilities 455.2m
Long-Term Debt 300m
Other Non-Current Liabilities 155.2m
Efficiency

Earnings Waterfall
Bio-Techne Corp

Revenue
1.4B USD
Cost of Revenue
-490.9m USD
Gross Profit
957.6m USD
Operating Expenses
-656.5m USD
Operating Income
301.1m USD
Other Expenses
-99.5m USD
Net Income
201.7m USD

Free Cash Flow Analysis
Bio-Techne Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

TECH Profitability Score
Profitability Due Diligence

Bio-Techne Corp's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Years Revenue Growth
63/100
Profitability
Score

Bio-Techne Corp's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

TECH Solvency Score
Solvency Due Diligence

Bio-Techne Corp's solvency score is 92/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
92/100
Solvency
Score

Bio-Techne Corp's solvency score is 92/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TECH Price Targets Summary
Bio-Techne Corp

Wall Street analysts forecast TECH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TECH is 87.11 USD with a low forecast of 75.75 USD and a high forecast of 99.75 USD.

Lowest
Price Target
75.75 USD
4% Upside
Average
Price Target
87.11 USD
19% Upside
Highest
Price Target
99.75 USD
37% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for TECH?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for TECH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

TECH Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

TECH News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one TECH stock?

The intrinsic value of one TECH stock under the Base Case scenario is 57.79 USD.

Is TECH stock undervalued or overvalued?

Compared to the current market price of 73.03 USD, Bio-Techne Corp is Overvalued by 21%.

Back to Top